Skip to content

Knowledge Center

News

Resonetics Announces Recapitalization with GTCR’s Regatta Medical

Regatta Medical to Support Growth of Market-Leader in Micromanufacturing for the Life Sciences

Resonetics announced today that Regatta Medical has made a strategic investment in Resonetics. Led by CEO Chip Hance, Regatta Medical is a portfolio company of GTCR, a leading private equity investor in the healthcare sector. Going forward, the existing Resonetics management team, led by CEO Tom Burns, will continue in their existing roles as a subsidiary of Regatta Medical.

Follow to Read the Full Release

whitepapers
Introduction to Nitinol
news
Resonetics Completes Acquisition of Memry and SAES Smart Materials
news
Resonetics Introduces New Contego 200 mAh Primary Battery
news
Resonetics and Resonant Link Announce Partnership